Literature DB >> 7158753

Midazolam, a water-soluble benzodiazepine, for gastroscopy.

T Brophy, J W Dundee, V Heazelwood, P Kawar, A Varghese, M Ward.   

Abstract

Midazolam, a water-soluble benzodiazepine, was given intravenously in doses of 0.07 mg/kg as sedation prior to oesophago-gastro-duodenoscopy in 40 patients. This was very effective as a sedative in elderly patients but less so in the young, with a large individual variation in response. Pain on injection and venous thrombosis which are common with diazepam were not seen with midazolam.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7158753     DOI: 10.1177/0310057X8201000409

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  6 in total

1.  A comparison of diazepam and midazolam as endoscopy premedication assessing changes in ventilation and oxygen saturation.

Authors:  G D Bell; A Morden; T Coady; J Lee; R F Logan
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  Diazepam or midazolam for endoscopy.

Authors:  J W Dundee; J P Fee
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

3.  Sedation for gastroscopy: a comparative study of midazolam and Diazemuls in patients with and without cirrhosis.

Authors:  N A Hamdy; H J Kennedy; J Nicholl; D R Triger
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

Review 4.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

5.  Midazolam for upper gastrointestinal endoscopy.

Authors:  P Kawar; K G Porter; E K Hunter; J McLaughlin; J W Dundee; T O Brophy
Journal:  Ann R Coll Surg Engl       Date:  1984-07       Impact factor: 1.891

6.  Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient.

Authors:  G D Bell; G P Spickett; P A Reeve; A Morden; R F Logan
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.